A biopharmaceutical company plans to open a 180,000-square-foot facility in Elwood.
According to a news release from Doniphan County Economic Development, Kindred Biosciences, Inc., announced Tuesday that it has acquired a manufacturing facility in Elwood, Kansas. The purchase of this property, formerly owned by Boehringer Ingelheim and by Strategic Veterinary Pharmaceuticals, Inc., includes approximately 8 acres of land and two buildings encompassing approximately 180,000 square feet with clean rooms, utility, equipment, and related quality documentation suitable for small molecule and biologics manufacturing. The total purchase price was $3,750,000 and the company expects to close within 30-days.
“It was pleasure working with Kindred Bio and other area partners to help facilitate the entrance of such a fantastic company and employer to Doniphan County,” said Adrienne Korson, Director of Economic Development in Doniphan County. “We look forward to helping assist in the future success of such a promising and cutting-edge enterprise, as KindredBio grows and fortifies our area as an important part of the animal health corridor.”
The St. Joseph Chamber of Commerce also sent out a release due to the proximity to St. Joseph and the impact the business will have on the area. The St. Joseph Chamber said Kindred Biosciences selected the location due to its ability to meet the anticipated manufacturing needs of its pipeline, lower its costs of goods and increase its margins.
“We are pleased to welcome Kindred Biosciences to the St. Joseph area to join other animal health companies in the community,” said R. Patt Lilly, President and CEO of the St. Joseph Chamber of Commerce. “The new jobs and investment will be welcomed by our neighbors in Elwood and further solidifies St. Joseph as a major player in the animal health corridor.”
According to the the company’s website, Kindred Biosciences is a development-stage biopharmaceutical company focused on saving and improving the lives of pets. Its mission is to bring to pets the same kinds of safe and effective medicines that human family members enjoy. The Company’s strategy is to identify compounds and targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated compounds and targets for dogs, cats and horses. The Company has a deep pipeline of novel drugs and biologics in development across many therapeutic classes.
Both Doniphan County and the St. Joseph Chamber of Commerce said no information on the number of jobs to be created is available at this time.